Document is current
Any future updates will be listed below
-
Authors
Harrison, Ewan M. https://orcid.org/0000-0003-2720-0507
Ba, Xiaoliang https://orcid.org/0000-0002-3882-3585
Coll, Francesc https://orcid.org/0000-0002-7882-2325
Blane, Beth https://orcid.org/0000-0002-0996-9091
Restif, Olivier
Carvell, Henry
Köser, Claudio U. https://orcid.org/0000-0002-0232-846X
Jamrozy, Dorota https://orcid.org/0000-0002-5703-9315
Reuter, Sandra
Lovering, Andrew
Gleadall, Nicholas
Bellis, Katherine L. https://orcid.org/0000-0001-5368-7027
Uhlemann, Anne-Catrin
Lowy, Franklin D.
Massey, Ruth C. https://orcid.org/0000-0002-8154-4039
Grilo, Inês R. https://orcid.org/0000-0002-5862-5738
Sobral, Rita
Larsen, Jesper
Rhod Larsen, Anders
Vingsbo Lundberg, Carina
Parkhill, Julian https://orcid.org/0000-0002-7069-5958
Paterson, Gavin K.
Holden, Matthew T. G. https://orcid.org/0000-0002-4958-2166
Peacock, Sharon J. https://orcid.org/0000-0002-1718-2782
Holmes, Mark A.
- License Information
-
More Information
Article History
Received: 21 February 2019
Accepted: 26 April 2019
First Online: 24 June 2019
Competing interests
: C.U.K. is a consultant for the World Health Organization Regional Office for Europe, QuantuMDx Group and Foundation for Innovative New Diagnostics, which involves work for Cepheid, Hain Lifescience and the World Health Organization. C.U.K. is an advisor to GenoScreen. The European Society of Mycobacteriology awarded C.U.K. the Gertrud Meissner Award, which is sponsored by Hain Lifescience. The Bill and Melinda Gates Foundation, Janssen Pharmaceutica and PerkinElmer covered C.U.K.’s travel and accommodation to enable presentations at meetings. The Global Alliance for TB Drug Development and Otsuka Novel Products have supplied C.U.K. with antibiotics for in vitro research. C.U.K. has collaborated with Illumina on a number of scientific projects. S.J.P. and J.P. are consultants to Next Gen Diagnostics. S.J.P. is a consultant to Specific Technologies. All other authors have no competing interests.
